Exane BNP Paribas initiated coverage of Veeva with an Outperform rating and $286 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- Veeva announces 18 of top 20 medtech companies use its Cloud applications
- Veeva price target raised to $249 from $233 at Guggenheim
- Veeva Systems Welcomes Brian Van Wagener as New CFO
- Veeva price target raised to $208 from $203 at JPMorgan
- Veeva price target raised to $207 from $197 at Truist